July 22, 2014 7:16 PM ET

Biotechnology

Company Overview of Lifecore Biomedical, LLC

Company Overview

Lifecore Biomedical, LLC develops, manufactures, and markets advanced sodium hyaluronan based products. It offers pharmaceutical grade sodium hyaluronate produced by a microbial fermentation process and is used in various medical applications. The company’s products also include Corgel BioHydrogel, a biocompatible, patented hyaluronan hydrogel based on di-hydroxyphenyl linkages of tyramine substituted sodium hyaluronate; and oligosaccharides and Mw ladders for the academic and corporate research communities. It also offers design and development, contract fermentation and purification, and aseptic filling services. In addition, it offers clinical products, such as Lurocoat, a ophthalmic visc...

3515 Lyman Boulevard

Chaska, MN 55318

United States

Founded in 1965

241 Employees

Phone:

952-368-4300

Fax:

952-368-3411

Key Executives for Lifecore Biomedical, LLC

President
Age: 58
Director of Finance
Chairman of Landec Corp and Chief Executive Officer of Landec Corp
Age: 65
Chief Scientific Officer and Vice President
Age: 59
Vice President of New Business Development
Age: 49
Compensation as of Fiscal Year 2014.

Lifecore Biomedical, LLC Key Developments

Lifecore Reports Earnings Results for the Fourth Quarter and Full Year Ended May 26, 2013; Provides Earnings Guidance for 2014

Lifecore reported earnings results for the fourth quarter and full year ended May 26, 2013. For the quarter, the company reported revenues of $8.238 million compared to $6.861 million a year ago. Net income was $0.945 million compared to $0.402 million a year ago. For the year, the company reported revenues of $41.281 million compared to $34.283 million a year ago. Net income was $9.414 million compared to $7.672 million a year ago. For fiscal 2014, the company expects that revenues will grow approximately 10% to 15% and pre-tax net income will grow approximately 20%.

Lifecore Biomedical, LLC Announces Resignation of Dennis J. Allingham as President and Chief Executive Officer

On May 6, 2013, Dennis J. Allingham tendered his resignation as president and chief executive officer of Lifecore Biomedical, LLC, and effective June 1, 2013.

Lifecore Biomedical, LLC Announces Unaudited Earnings Results for the Fourth Quarter and Full Year Ended May 27, 2012; Provides Earnings Guidance for Fiscal Year 2013

Lifecore Biomedical, LLC announced unaudited earnings results for the fourth quarter and full year ended May 27, 2012. For the quarter, the company reported revenues of $6.861 million against $5.542 million a year ago. Net income was $0.402 million against net loss of $0.455 million a year ago. For the fiscal year 2012, the company reported revenues of $34.283 million against $32.505 million a year ago. Net income was $7.672 million against $7.278 million a year ago. For fiscal year 2013, the company expects an increase in revenue of $4 million to $6 million, increase in pre-tax income of $1.0 million to $1.6 million.

Similar Private Companies By Industry

Company Name Region
Labrys Biologics, Inc. United States
Applied StemCell, Inc. United States
ProGDerm Inc. United States
Biodesign International, Inc. United States
BioProtect Corporation United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Lifecore Biomedical, LLC, please visit www.lifecore.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.